Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Natus Medical Inc : Natus Medical to Hold 2012 First Quarter Financial Results Conference Call on April 26

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/17/2012 | 01:05pm CET

Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company intends to release its 2012 first quarter financial results before the market opens on Thursday, April 26, 2012. Natus management will host an investment-community conference call the same day beginning at 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer questions.

Individuals interested in listening to the conference call may do so by dialing 888-268-4176 for domestic callers, or 1-617-597-5493 for international callers, and entering reservation code 32875965. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 888-286-8010 for domestic callers, or 1-617-801-6888 for international callers, and entering reservation code 56980616.

The conference call also will be available real-time via the Internet at http://investor.natus.com, and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, 650-802-0400
InvestorRelations@Natus.com
Vice President and Chief Financial Officer


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
04:28p NATUS MEDICAL INC : Lundin Law PC Announces Securities Class Action Lawsuit agai..
03/23 NATUS MEDICAL INC : Faruqi & Faruqi, LLP Reminds Investors in Natus Medical Inco..
03/23 NATUS MEDICAL INC : Khang & Khang LLP Announces Securities Class Action Lawsuit ..
03/22 NATUS MEDICAL INC : INVESTOR NOTICE: Lundin Law PC Announces Securities Class Ac..
03/21 DEADLINE ALERT : Brower Piven Reminds Investors of the March 31, 2017 Deadline i..
03/21 Levi & Korsinsky, LLP Reminds Shareholders of Natus Medical Incorporated of a..
03/20 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Financial Statements and..
03/20 NATUS MEDICAL : Financial Statements and Exhibits (form 8-K/A)
03/18 Lundin Law PC Announces Securities Class Action Lawsuit against Natus Medical..
03/18 JOHNSON & WEAVER, LLP : Files Class Action Suit against Natus Medical Incorporat..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
03/14 Natus Medical (BABY) Presents At 29th Annual ROTH Conference
03/07 Natus Medical (BABY) Presents At The Raymond James 38th Annual Institutional ..
02/02 Premarket analyst action - healthcare
02/01 Natus Medical's (BABY) CEO Jim Hawkins on Q4 2016 Results - Earnings Call Tra..
02/01 Natus Medical revenues up 8%; earnings up 20% in Q4; updates Q1 and 2017 guid..
Advertisement
Financials ($)
Sales 2017 504 M
EBIT 2017 74,0 M
Net income 2017 50,6 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 25,22
P/E ratio 2018 18,87
Capi. / Sales 2017 2,51x
Capi. / Sales 2018 2,46x
Capitalization 1 265 M
More Financials
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Full-screen chart
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 51,0 $
Spread / Average Target 32%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer, EVP & IR Contact
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC10.63%1 265
THERMO FISHER SCIENTIF..9.60%60 374
DANAHER CORPORATION10.87%59 830
BOSTON SCIENTIFIC CORP..12.11%33 065
PHILIPS2.02%29 603
INTUITIVE SURGICAL, IN..17.66%27 404
More Results